Matches in SemOpenAlex for { <https://semopenalex.org/work/W4280508737> ?p ?o ?g. }
- W4280508737 endingPage "71" @default.
- W4280508737 startingPage "64" @default.
- W4280508737 abstract "Recurrent waves of COVID19 remain a major global health concern. Repurposing either FDA-approved or clinically advanced drug candidates can save time and effort required for validating the safety profile and FDA approval. However, the selection of appropriate screening approaches is key to identifying novel candidate drugs with a higher probability of clinical success. Here, we report a rapid, stratified two-step screening approach using pseudovirus entry inhibition assay followed by an infectious prototypic SARS CoV2 cytotoxic effect inhibition assay in multiple cell lines. Using this approach, we screened a library of FDA-approved and clinical-stage drugs and identified four compounds, apilimod, berbamine, cepharanthine and (S)-crizotinib which potently inhibited SARS CoV2-induced cell death. Importantly, these drugs exerted similar inhibitory effect on the delta and omicron variants although they replicated less efficiently than the prototypic strain. Apilimod is currently under clinical trial (NCT04446377) for COVID19 supporting the validity and robustness of our screening approach." @default.
- W4280508737 created "2022-05-22" @default.
- W4280508737 creator A5004707957 @default.
- W4280508737 creator A5022299669 @default.
- W4280508737 creator A5031674961 @default.
- W4280508737 creator A5039514819 @default.
- W4280508737 creator A5052793273 @default.
- W4280508737 creator A5061765564 @default.
- W4280508737 creator A5070699513 @default.
- W4280508737 creator A5079657055 @default.
- W4280508737 date "2022-07-01" @default.
- W4280508737 modified "2023-10-06" @default.
- W4280508737 title "Identification of potential COVID-19 treatment compounds which inhibit SARS Cov2 prototypic, Delta and Omicron variant infection" @default.
- W4280508737 cites W1967666468 @default.
- W4280508737 cites W1981258651 @default.
- W4280508737 cites W2006286994 @default.
- W4280508737 cites W2037345530 @default.
- W4280508737 cites W2074963337 @default.
- W4280508737 cites W2104548316 @default.
- W4280508737 cites W2122991277 @default.
- W4280508737 cites W2751866419 @default.
- W4280508737 cites W2770333021 @default.
- W4280508737 cites W3005212621 @default.
- W4280508737 cites W3009912996 @default.
- W4280508737 cites W3010673910 @default.
- W4280508737 cites W3036391214 @default.
- W4280508737 cites W3044416430 @default.
- W4280508737 cites W3044927477 @default.
- W4280508737 cites W3047775844 @default.
- W4280508737 cites W3096967708 @default.
- W4280508737 cites W3110466220 @default.
- W4280508737 cites W3110790785 @default.
- W4280508737 cites W3128335178 @default.
- W4280508737 cites W3129925610 @default.
- W4280508737 cites W3149537966 @default.
- W4280508737 cites W3151076337 @default.
- W4280508737 cites W3156990363 @default.
- W4280508737 cites W3157898654 @default.
- W4280508737 cites W3168461337 @default.
- W4280508737 cites W3173547614 @default.
- W4280508737 cites W3182094313 @default.
- W4280508737 cites W3182882252 @default.
- W4280508737 cites W4200625712 @default.
- W4280508737 cites W4206153788 @default.
- W4280508737 cites W4210308999 @default.
- W4280508737 cites W4210665241 @default.
- W4280508737 cites W4210787373 @default.
- W4280508737 cites W4224820446 @default.
- W4280508737 cites W4226164088 @default.
- W4280508737 cites W4226280844 @default.
- W4280508737 cites W4286218372 @default.
- W4280508737 doi "https://doi.org/10.1016/j.virol.2022.05.004" @default.
- W4280508737 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/35598394" @default.
- W4280508737 hasPublicationYear "2022" @default.
- W4280508737 type Work @default.
- W4280508737 citedByCount "9" @default.
- W4280508737 countsByYear W42805087372023 @default.
- W4280508737 crossrefType "journal-article" @default.
- W4280508737 hasAuthorship W4280508737A5004707957 @default.
- W4280508737 hasAuthorship W4280508737A5022299669 @default.
- W4280508737 hasAuthorship W4280508737A5031674961 @default.
- W4280508737 hasAuthorship W4280508737A5039514819 @default.
- W4280508737 hasAuthorship W4280508737A5052793273 @default.
- W4280508737 hasAuthorship W4280508737A5061765564 @default.
- W4280508737 hasAuthorship W4280508737A5070699513 @default.
- W4280508737 hasAuthorship W4280508737A5079657055 @default.
- W4280508737 hasBestOaLocation W42805087371 @default.
- W4280508737 hasConcept C103637391 @default.
- W4280508737 hasConcept C126322002 @default.
- W4280508737 hasConcept C159047783 @default.
- W4280508737 hasConcept C18903297 @default.
- W4280508737 hasConcept C2776232967 @default.
- W4280508737 hasConcept C2779134260 @default.
- W4280508737 hasConcept C2779422266 @default.
- W4280508737 hasConcept C2779634585 @default.
- W4280508737 hasConcept C2780035454 @default.
- W4280508737 hasConcept C3007834351 @default.
- W4280508737 hasConcept C3008058167 @default.
- W4280508737 hasConcept C519536355 @default.
- W4280508737 hasConcept C524204448 @default.
- W4280508737 hasConcept C535046627 @default.
- W4280508737 hasConcept C60644358 @default.
- W4280508737 hasConcept C70721500 @default.
- W4280508737 hasConcept C71924100 @default.
- W4280508737 hasConcept C86803240 @default.
- W4280508737 hasConcept C98274493 @default.
- W4280508737 hasConceptScore W4280508737C103637391 @default.
- W4280508737 hasConceptScore W4280508737C126322002 @default.
- W4280508737 hasConceptScore W4280508737C159047783 @default.
- W4280508737 hasConceptScore W4280508737C18903297 @default.
- W4280508737 hasConceptScore W4280508737C2776232967 @default.
- W4280508737 hasConceptScore W4280508737C2779134260 @default.
- W4280508737 hasConceptScore W4280508737C2779422266 @default.
- W4280508737 hasConceptScore W4280508737C2779634585 @default.
- W4280508737 hasConceptScore W4280508737C2780035454 @default.
- W4280508737 hasConceptScore W4280508737C3007834351 @default.
- W4280508737 hasConceptScore W4280508737C3008058167 @default.
- W4280508737 hasConceptScore W4280508737C519536355 @default.